Cannabis Sativa Inc (OTCMKTS:CBDS) insider Donald Lundbom sold 4,000 shares of the firm’s stock in a transaction on Monday, March 11th. The stock was sold at an average price of $3.17, for a total value of $12,680.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Donald Lundbom also recently made the following trade(s):
- On Friday, January 11th, Donald Lundbom sold 7,972 shares of Cannabis Sativa stock. The shares were sold at an average price of $3.87, for a total value of $30,851.64.
- On Tuesday, January 8th, Donald Lundbom sold 10,000 shares of Cannabis Sativa stock. The shares were sold at an average price of $3.21, for a total value of $32,100.00.
Shares of CBDS traded down $0.12 during trading hours on Thursday, hitting $2.97. The company had a trading volume of 40,897 shares, compared to its average volume of 86,440. Cannabis Sativa Inc has a 52-week low of $1.92 and a 52-week high of $8.50.
ILLEGAL ACTIVITY WARNING: “Cannabis Sativa Inc (CBDS) Insider Donald Lundbom Sells 4,000 Shares” was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://www.com-unik.info/2019/03/14/cannabis-sativa-inc-cbds-insider-donald-lundbom-sells-4000-shares.html.
Cannabis Sativa, Inc, through its subsidiaries, develops, manufactures, and sells herbal based skin care products in the United States and internationally. The company offers Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm.
Recommended Story: Cost of Equity For A Business, Investors
Receive News & Ratings for Cannabis Sativa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannabis Sativa and related companies with MarketBeat.com's FREE daily email newsletter.